Microbix Biosystems Inc.

TSX:MBX Stock Report

Market Cap: CA$55.6m

Microbix Biosystems Management

Management criteria checks 3/4

Microbix Biosystems' CEO is Cameron Groome, appointed in Jul 2017, has a tenure of 7.5 years. total yearly compensation is CA$476.58K, comprised of 85.3% salary and 14.7% bonuses, including company stock and options. directly owns 2.21% of the company’s shares, worth CA$1.23M. The average tenure of the management team and the board of directors is 8 years and 17.9 years respectively.

Key information

Cameron Groome

Chief executive officer

CA$476.6k

Total compensation

CEO salary percentage85.3%
CEO tenure7.5yrs
CEO ownership2.2%
Management average tenure8yrs
Board average tenure17.9yrs

Recent management updates

Recent updates

Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Aug 22
Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Feb 21
Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 17
Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Dec 23
Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Nov 03
Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Jul 22
Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

May 17
Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Dec 27
Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Aug 08
Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

May 20
Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

Feb 06
Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Dec 28
One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Oct 14
Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 15
Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

May 17
A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

Mar 24
Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

We Think Microbix Biosystems (TSE:MBX) Has A Fair Chunk Of Debt

Jan 29
We Think Microbix Biosystems (TSE:MBX) Has A Fair Chunk Of Debt

CEO Compensation Analysis

How has Cameron Groome's remuneration changed compared to Microbix Biosystems's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

CA$4m

Jun 30 2024n/an/a

CA$5m

Mar 31 2024n/an/a

CA$4m

Dec 31 2023n/an/a

CA$4m

Sep 30 2023CA$477kCA$406k

-CA$39k

Jun 30 2023n/an/a

-CA$3m

Mar 31 2023n/an/a

-CA$1m

Dec 31 2022n/an/a

-CA$391k

Sep 30 2022CA$537kCA$388k

CA$2m

Jun 30 2022n/an/a

CA$3m

Mar 31 2022n/an/a

CA$4m

Dec 31 2021n/an/a

CA$4m

Sep 30 2021CA$598kCA$311k

CA$3m

Jun 30 2021n/an/a

-CA$3m

Mar 31 2021n/an/a

-CA$4m

Dec 31 2020n/an/a

-CA$6m

Sep 30 2020CA$363kCA$305k

-CA$6m

Jun 30 2020n/an/a

-CA$1m

Mar 31 2020n/an/a

-CA$1m

Dec 31 2019n/an/a

-CA$434k

Sep 30 2019CA$313kCA$281k

CA$32k

Jun 30 2019n/an/a

-CA$8m

Mar 31 2019n/an/a

-CA$8m

Dec 31 2018n/an/a

-CA$9m

Sep 30 2018CA$306kCA$250k

-CA$9m

Compensation vs Market: Cameron's total compensation ($USD330.93K) is above average for companies of similar size in the Canadian market ($USD166.88K).

Compensation vs Earnings: Cameron's compensation has been consistent with company performance over the past year.

CEO

Cameron Groome

7.5yrs

Tenure

CA$476,575

Compensation

Mr. Cameron L. Groome is Director of Naegis Pharmaceuticals Inc. He serves as an Independent Director at iFabric Corp. since March 30, 2020. Mr. Groome has been the Chief Executive Officer and President of...

Leadership Team

NamePositionTenureCompensationOwnership
Cameron Groome
President7.5yrsCA$476.58k2.21%
CA$ 1.2m
James Currie
Chief Financial Officer8yrsCA$312.52k0.20%
CA$ 112.7k
Kenneth Hughes
Chief Operating Officer5.6yrsCA$312.58k0.34%
CA$ 186.6k
Philip Casselli
Senior Vice President of Sales12.2yrsCA$292.92k0.46%
CA$ 254.8k
Mark Luscher
Senior Vice President of Scientific Affairs17.2yrsCA$277.11k0.27%
CA$ 151.6k
Christopher Lobb
Compliance Officerno datano datano data

8.0yrs

Average Tenure

Experienced Management: MBX's management team is seasoned and experienced (8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Cameron Groome
President12.8yrsCA$476.58k2.21%
CA$ 1.2m
Mark Cochran
Independent Director22.3yrsno data0.41%
CA$ 225.2k
Joseph Renner
Independent Director21.9yrsno data6.96%
CA$ 3.9m
Martin Marino
Independent Chairman of the Board15.9yrsno data1.08%
CA$ 601.3k
Peter Blecher
Independent Director19.1yrsno data2.08%
CA$ 1.2m
Vaughn Embro-Pantalony
Independent Director17.9yrsno data1.27%
CA$ 703.9k
Jennifer Stewart
Independent Director2.8yrsno data0.010%
CA$ 5.7k

17.9yrs

Average Tenure

Experienced Board: MBX's board of directors are seasoned and experienced ( 17.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 00:49
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Microbix Biosystems Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MartinBloom Burton & Co.
Neil LinsdelliA Capital Markets